NXGL Stock Price Chart
NXGL Financial
Nexgel Inc
$0.48
19.28%
$0.07
At close: Aug 13, 16:00:00 GMT-4
$0.55
13.54%
$0.06
Post-market: Aug 13, 20:00:00 GMT-4
Back
Nexgel Inc (NXGL) Financial
Income
Balance sheet
Cash flow
Annual
Quarterly
NXGL Income
Financials in millions USD. Fiscal year is February - January.
Follow-Up Questions
What are Nexgel Inc's key financial statements?
What are the key financial ratios for NXGL?
How is Nexgel Inc's revenue broken down by segment or geography?
Is Nexgel Inc profitable?
Does Nexgel Inc have any liabilities?
How many outstanding shares for Nexgel Inc?
Key Stats
Prev.Close
$0.4097
Open
$0.4099
Day's Range
$0.4 - $0.5549
52 week range
$0.3303 - $2.88
Volume
1.4M
Avg.Volume
261.7K
Dividend yield
--
EPS (TTM)
-0.40
Market Cap
$5.1M
What is NXGL?
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Langhorne, Pennsylvania and currently employs 19 full-time employees. The company went IPO on 2021-12-22. The company is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The firm operates through two segments: NexGel and CGN. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CGN segment comprises CG Converting and Packaging, LLC (CGN), a joint venture with C.G. Laboratories Inc. (CG Labs) used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Silly George.
